Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 41
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Arch Toxicol ; 97(3): 875-889, 2023 03.
Artículo en Inglés | MEDLINE | ID: mdl-36564592

RESUMEN

Although micronuclei are well-known biomarkers of genotoxic damage, the biological consequences of micronucleus induction are only poorly understood. To further elucidate these consequences, HeLa cells stably expressing histone 2B coupled with green fluorescent protein were used for long-term live cell imaging to investigate the fate of micronuclei and micronucleated cells after treatment of cells with various genotoxic agents (doxorubicin (20, 30 and nM), tert-butyl hydroperoxide (tBHP, 50, 100 and 150 µM), radiation (0.5, 1 and 2 Gy), methyl methanesulfonate (MMS, 20, 25 and 30 µg/ml) and vinblastine (1, 2 and 3 nM)). Most micronuclei persist for multiple cell cycles or reincorporate while micronucleated cells were more prone to cell death, senescence and fatal mitotic errors compared to non-micronucleated cells, which is consistent with previous studies using etoposide. No clear substance-related effects on the fate of micronuclei and micronucleated cells were observed. To further investigate the fate of micronuclei, extrusion of micronuclei was studied with treatments reported as inducing the extrusion of micronuclei. Since extrusion was not observed in HeLa cells, the relevance of extrusion of micronuclei remains unclear. In addition, degradation of micronuclei was analysed via immunostaining of γH2AX, which demonstrated a high level of DNA damage in micronuclei compared to the main nuclei. Furthermore, transduction with two reporter genes (LC3B-dsRed and LaminB1-dsRed) was conducted followed by long-term live cell imaging. While autophagy marker LC3B was not associated with micronuclei, Lamin B1 was found in approximately 50% of all micronuclei. While degradation of micronuclei was not observed to be a frequent fate of micronuclei, the results show impaired stability of DNA and micronuclear envelope indicating rupture of micronuclei as a pre-step to chromothripsis.


Asunto(s)
Núcleo Celular , Micronúcleos con Defecto Cromosómico , Humanos , Células HeLa , Núcleo Celular/metabolismo , Daño del ADN , Histonas/metabolismo , Pruebas de Micronúcleos
2.
Arch Toxicol ; 94(10): 3553-3561, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-32681187

RESUMEN

Micronuclei are small nuclear cellular structures containing whole chromosomes or chromosomal fragments. While there is a lot of information available about the origin and formation of micronuclei, less is known about the fate of micronuclei and micronucleated cells. Possible fates include extrusion, degradation, reincorporation and persistence. Live cell imaging was performed to quantitatively analyse the fates of micronuclei and micronucleated cells occurring in vitro. Imaging was conducted for up to 96 h in HeLa-H2B-GFP cells treated with 0.5, 1 and 2 µg/ml etoposide. While a minority of micronuclei was reincorporated into the main nucleus during mitosis, the majority of micronuclei persisted without any alterations. Degradation and extrusion were observed rarely or never. The presence of micronuclei affected the proliferation of the daughter cells and also had an influence on cell death rates. Mitotic errors were found to be clearly increased in micronucleus-containing cells. The results show that micronuclei and micronucleated cells can, although delayed in cell cycle, sustain for multiple divisions.


Asunto(s)
Núcleo Celular/metabolismo , Etopósido/farmacología , Micronúcleos con Defecto Cromosómico/efectos de los fármacos , Antineoplásicos Fitogénicos/farmacología , Ciclo Celular/efectos de los fármacos , Muerte Celular , Línea Celular , Proliferación Celular , Proteínas Fluorescentes Verdes/análisis , Células HeLa , Humanos , Imagenología Tridimensional , Pruebas de Micronúcleos , Microscopía Fluorescente , Mitosis , Análisis de la Célula Individual , Imagen de Lapso de Tiempo
3.
Molecules ; 24(21)2019 Nov 03.
Artículo en Inglés | MEDLINE | ID: mdl-31684176

RESUMEN

Eugenol is a phytochemical present in different plant products, e.g., clove oil. Traditionally, it is used against a number of different disorders and it was suggested to have anticancer activity. In this study, the activity of eugenol was evaluated in a human cervical cancer (HeLa) cell line and cell proliferation was examined after treatment with various concentrations of eugenol and different treatment durations. Cytotoxicity was tested using lactate dehydrogenase (LDH) enzyme leakage. In order to assess eugenol's potential to act synergistically with chemotherapy and radiotherapy, cell survival was calculated after eugenol treatment in combination with cisplatin and X-rays. To elucidate its mechanism of action, caspase-3 activity was analyzed and the expression of various genes and proteins was checked by RT-PCR and western blot analyses. Eugenol clearly decreased the proliferation rate and increased LDH release in a concentration- and time-dependent manner. It showed synergistic effects with cisplatin and X-rays. Eugenol increased caspase-3 activity and the expression of Bax, cytochrome c (Cyt-c), caspase-3, and caspase-9 and decreased the expression of B-cell lymphoma (Bcl)-2, cyclooxygenase-2 (Cox-2), and interleukin-1 beta (IL-1ß) indicating that eugenol mainly induced cell death by apoptosis. In conclusion, eugenol showed antiproliferative and cytotoxic effects via apoptosis and also synergism with cisplatin and ionizing radiation in the human cervical cancer cell line.


Asunto(s)
Antineoplásicos/farmacología , Eugenol/farmacología , Neoplasias del Cuello Uterino/tratamiento farmacológico , Neoplasias del Cuello Uterino/radioterapia , Apoptosis/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Cisplatino/farmacología , Terapia Combinada , Resistencia a Antineoplásicos/efectos de los fármacos , Sinergismo Farmacológico , Femenino , Células HeLa , Humanos , Neoplasias del Cuello Uterino/patología
4.
Cytometry A ; 93(3): 305-313, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-28544333

RESUMEN

The spleen selectively removes cells with intracellular inclusions, for example, detached nuclear fragments in circulating erythrocytes, called Howell-Jolly Bodies (HJBs). With absent or deficient splenic function HJBs appear in the peripheral blood and can be used as a simple and non-invasive risk-indicator for fulminant potentially life-threatening infection after spleenectomy. However, it is still under debate whether counting of the rare HJBs is a reliable measure of splenic function. Investigating HJBs in premature erythrocytes from patients during radioiodine therapy gives about 10 thousand times higher HJB counts than in blood smears. However, we show that there is still the risk of false-positive results by unspecific nuclear remnants in the prepared samples that do not originate from HJBs, but from cell debris residing above or below the cell. Therefore, we present a method to improve accuracy of image-based tests that can be performed even in non-specialized medical institutions. We show how to selectively label HJB-like clusters in human blood samples and how to only count those that are undoubtedly inside the cell. We found a "critical distance" dcrit referring to a relative HJB-Cell distance that true HJBs do not exceed. To rule out false-positive counts we present a simple inside-outside-rule based on dcrit -a robust threshold that can be easily assessed by combining conventional 2D imaging and straight-forward image analysis. Besides data based on fluorescence imaging, simulations of randomly distributed HJB-like objects on realistically modelled cell objects demonstrate the risk and impact of biased counting in conventional analysis. © 2017 The Authors. Cytometry Part A published by Wiley Periodicals, Inc. on behalf of ISAC.


Asunto(s)
Inclusiones Eritrocíticas/fisiología , Eritrocitos/citología , Procesamiento de Imagen Asistido por Computador/métodos , Imagen Óptica/mortalidad , Bazo/metabolismo , Humanos , Radioisótopos de Yodo/efectos adversos , Microscopía Confocal/métodos , Modelos Biológicos
5.
Biospektrum (Heidelb) ; 29(1): 56-57, 2023.
Artículo en Alemán | MEDLINE | ID: mdl-36845578
6.
Biospektrum (Heidelb) ; 28(3): 296, 2022.
Artículo en Alemán | MEDLINE | ID: mdl-35615209
7.
Biospektrum (Heidelb) ; 28(2): 176-177, 2022.
Artículo en Alemán | MEDLINE | ID: mdl-35369112
8.
Biospektrum (Heidelb) ; 28(4): 406-407, 2022.
Artículo en Alemán | MEDLINE | ID: mdl-35698576
9.
Biospektrum (Heidelb) ; 28(1): 58-59, 2022.
Artículo en Alemán | MEDLINE | ID: mdl-35194335
10.
Mutagenesis ; 31(1): 27-33, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26152226

RESUMEN

Experiments were performed to evaluate the in vitro and in vivo dose response for antigenotoxic effects of resveratrol (RES). For the in vitro study, HL-60 cells were co-treated with the test genotoxin and three concentrations of RES. Thereafter, genotoxic effects were assessed in the cytokinesis-block micronucleus test. Results of the in vitro experiments using genotoxins nitroquinoline-1-oxide (NQO) and mitomycin C (MMC) showed maximum inhibition of genotoxicity with the lowest test concentration of RES. The mouse bone marrow micronucleus assay was used for evaluating the in vivo antigenotoxic effects of RES against genotoxins diepoxybutane (DEB), MMC, methyl methanesulfonate and procarbazine (PCB). The experimental animals received RES pre-treatment by gavage 30min, 24 and 48h before injecting the genotoxin intraperitoneally. The in vivo studies demonstrated efficacy of the lowest test dose of RES for exerting maximum protection against chromosomal damage induced by all four genotoxins. The antigenotoxic effect observed with 6.25mg/kg RES was significantly higher than that of 100mg/kg RES against PCB and DEB. In conclusion, the findings from the present study indicate that lower test concentrations/doses of RES are more effective in exerting antigenotoxic effects.


Asunto(s)
Antimutagênicos/farmacología , Aberraciones Cromosómicas , Estilbenos/farmacología , 4-Nitroquinolina-1-Óxido/toxicidad , Animales , Células de la Médula Ósea/efectos de los fármacos , Cromosomas/efectos de los fármacos , Daño del ADN , Compuestos Epoxi/toxicidad , Células HL-60 , Humanos , Masculino , Metilmetanosulfonato/toxicidad , Ratones , Pruebas de Micronúcleos , Mitomicina/toxicidad , Procarbazina/toxicidad , Quinolonas/toxicidad , Resveratrol
11.
Biospektrum (Heidelb) ; 27(7): 734-735, 2021.
Artículo en Alemán | MEDLINE | ID: mdl-34840434
12.
Biospektrum (Heidelb) ; 27(3): 284-285, 2021.
Artículo en Alemán | MEDLINE | ID: mdl-33994675
13.
Biospektrum (Heidelb) ; 27(5): 516-517, 2021.
Artículo en Alemán | MEDLINE | ID: mdl-34511736
14.
Biospektrum (Heidelb) ; 27(6): 630-631, 2021.
Artículo en Alemán | MEDLINE | ID: mdl-34658538
15.
Biospektrum (Heidelb) ; 27(2): 176-177, 2021.
Artículo en Alemán | MEDLINE | ID: mdl-33776219
16.
Biospektrum (Heidelb) ; 27(4): 406-407, 2021.
Artículo en Alemán | MEDLINE | ID: mdl-34219985
17.
Biospektrum (Heidelb) ; 27(1): 60-61, 2021.
Artículo en Alemán | MEDLINE | ID: mdl-33612991
18.
Biospektrum (Heidelb) ; 26(4): 412-413, 2020.
Artículo en Alemán | MEDLINE | ID: mdl-32834538
19.
Biospektrum (Heidelb) ; 26(7): 753-754, 2020.
Artículo en Alemán | MEDLINE | ID: mdl-33250579
20.
Biospektrum (Heidelb) ; 26(5): 516-517, 2020.
Artículo en Alemán | MEDLINE | ID: mdl-32921926
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA